BioCentury | Mar 5, 2020
Management Tracks

Mott retires from NEA

...Dave Mott, the former Smith Barney investment banker, CEO of MedImmune and longtime VC, has announced his...
BioCentury | Jan 28, 2006
Company News

More Chiron shareholders oppose acquisition

...they will vote against the proposed acquisition of the company by Novartis (NVS; SWX:NOVN). CAM, Smith Barney...
BioCentury | Sep 6, 2004
Finance

Analyst picks & changes

...a E9 target. ECX closed Friday at E7.20, up E0.52 on the week. ImClone (IMCL) Smith Barney...
BioCentury | Aug 2, 2004
Finance

ImClone's royal(ty) pain

...reiterated his 2004 and 2005 Erbitux sales estimates of $243 million and $379 million. Citigroup Smith Barney...
BioCentury | Aug 2, 2004
Analyst Picks & Changes

Analyst picks & changes

...Thelin sitaxsentan oral endothelin A receptor antagonist to treat pulmonary arterial hypertension (PAH). ImClone (IMCL) Smith Barney...
BioCentury | Jul 26, 2004
Top Story

ImClone down on downgrade

Smith Barney analyst Yaron Werber dropped his rating on IMCL to "hold" from "buy" to reflect higher-than-expected royalty obligations that he said "would have a noticeable impact on its profitability." Werber also lowered his price...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...company Cellegy (CLGY) and dental and derm play Collagenex (CGPI). Analyst tracks Yaron Werber joined Smith Barney...
...Unterberg Towbin hired Angela Larson to cover specialty pharma. Previously, Larson covered specialty pharma for Smith Barney...
BioCentury | Mar 31, 2004
Financial News

Werber joins Smith Barney

...Yaron Werber joined Smith Barney as a senior biotechnology analyst. He had been with SG Cowen as...
...analyst for the past three years. He joins Elise Wang, a senior biotech analyst for Smith Barney...
BioCentury | Oct 20, 2003
Finance

Ebb & Flow

...'s strategy to expand its healthcare footprint. In July, it hired Glen Santangelo from Salomon Smith Barney...
BioCentury | May 26, 2003
Finance

Ebb & Flow

...conflicts of interest. Chatter hit the wires on Friday that Citigroup Capital Markets (formerly Solomon Smith Barney...
Items per page:
1 - 10 of 112
BioCentury | Mar 5, 2020
Management Tracks

Mott retires from NEA

...Dave Mott, the former Smith Barney investment banker, CEO of MedImmune and longtime VC, has announced his...
BioCentury | Jan 28, 2006
Company News

More Chiron shareholders oppose acquisition

...they will vote against the proposed acquisition of the company by Novartis (NVS; SWX:NOVN). CAM, Smith Barney...
BioCentury | Sep 6, 2004
Finance

Analyst picks & changes

...a E9 target. ECX closed Friday at E7.20, up E0.52 on the week. ImClone (IMCL) Smith Barney...
BioCentury | Aug 2, 2004
Finance

ImClone's royal(ty) pain

...reiterated his 2004 and 2005 Erbitux sales estimates of $243 million and $379 million. Citigroup Smith Barney...
BioCentury | Aug 2, 2004
Analyst Picks & Changes

Analyst picks & changes

...Thelin sitaxsentan oral endothelin A receptor antagonist to treat pulmonary arterial hypertension (PAH). ImClone (IMCL) Smith Barney...
BioCentury | Jul 26, 2004
Top Story

ImClone down on downgrade

Smith Barney analyst Yaron Werber dropped his rating on IMCL to "hold" from "buy" to reflect higher-than-expected royalty obligations that he said "would have a noticeable impact on its profitability." Werber also lowered his price...
BioCentury | Apr 5, 2004
Finance

Ebb & Flow

...company Cellegy (CLGY) and dental and derm play Collagenex (CGPI). Analyst tracks Yaron Werber joined Smith Barney...
...Unterberg Towbin hired Angela Larson to cover specialty pharma. Previously, Larson covered specialty pharma for Smith Barney...
BioCentury | Mar 31, 2004
Financial News

Werber joins Smith Barney

...Yaron Werber joined Smith Barney as a senior biotechnology analyst. He had been with SG Cowen as...
...analyst for the past three years. He joins Elise Wang, a senior biotech analyst for Smith Barney...
BioCentury | Oct 20, 2003
Finance

Ebb & Flow

...'s strategy to expand its healthcare footprint. In July, it hired Glen Santangelo from Salomon Smith Barney...
BioCentury | May 26, 2003
Finance

Ebb & Flow

...conflicts of interest. Chatter hit the wires on Friday that Citigroup Capital Markets (formerly Solomon Smith Barney...
Items per page:
1 - 10 of 112